Form 4: Solventum CAO Wilcox Exercises RSUs, Sells Shares for Tax
Insider Transaction Report
Solventum Corp's Chief Accounting Officer, Mary T. Wilcox, exercised vested Restricted Stock Units and subsequently sold a portion of the resulting common stock to cover tax withholding.
Summary
- Mary T. Wilcox, Chief Accounting Officer of Solventum Corp (SOLV), reported transactions on March 27, 2026.
- Exercised 5,199 Restricted Stock Units (RSUs) into Common Stock at an acquisition price of $0.
- Sold 1,591 shares of Common Stock at a price of $62.76 per share to satisfy tax withholding obligations.
- Following these transactions, Wilcox beneficially owns 5,256 shares of Solventum Corp Common Stock directly.
- The RSUs were fully vested, representing a contingent right to receive one share of Class A Common Stock per RSU.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine insider filing for equity compensation and tax purposes, which typically has no significant bearing on the company's operational or financial performance.
Positives
- The exercise of 5,199 vested Restricted Stock Units indicates the fulfillment of prior compensation agreements.
- The acquisition of shares from RSUs at a $0 price reflects a non-cash conversion of equity compensation.
Negatives
- The sale of 1,591 shares of Common Stock, even for tax purposes, reduces the direct beneficial ownership of the Chief Accounting Officer.
Risks
- While the sale was for tax purposes, any insider selling, regardless of reason, can sometimes be misinterpreted by the market as a lack of confidence, potentially leading to minor negative sentiment.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as the exercise of vested equity awards and subsequent sales for tax purposes, are common across all industries. These transactions typically reflect pre-planned compensation events rather than a change in the company's fundamental outlook or a strategic shift within the healthcare or industrial sectors where Solventum operates.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Mary T. Wilcox granted a Limited Power of Attorney to Megan Bombick and Kristen Brown to handle her Section 16 reporting obligations (Forms 3, 4, and 5) for Solventum Corporation securities. | 03/02/2026 | This streamlines compliance for the reporting person by authorizing designated individuals to prepare and file required SEC documents on her behalf, ensuring timely and accurate disclosures. |
Stakeholder Impact
- Shareholders: The sale of shares, even for tax, slightly reduces the insider's direct alignment with shareholder interests, though the overall impact is minimal given the routine nature and small volume relative to total shares outstanding.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Effective date of Limited Power of Attorney granted to Megan Bombick and Kristen Brown for Section 16 reporting obligations. |
| 03/27/2026 | Transaction date for the exercise of Restricted Stock Units and subsequent sale of Common Stock. |
| 03/30/2026 | Date the Form 4 was signed by the attorney-in-fact. |
| 08/12/2034 | Expiration date of the Restricted Stock Units. |
Keywords
Solventum, SOLV, Insider Trading, Form 4, Restricted Stock Units, RSU, Equity Compensation, Chief Accounting Officer, Mary T. Wilcox, Stock Sale, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.